`
`
`
`
`Filed on behalf of: KVK-Tech, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Filed January 24, 2019
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`______________________
`
`KVK-Tech, Inc.
`Petitioner
`
`v.
`
`Shire PLC
`Patent Owner
`
`______________________
`Case IPR2018-00290
`U.S. Pat. No. 8,846,100
`______________________
`DECLARATION OF DAVID J. GALLUZZO IN SUPPORT OF
`MOTION FOR ADMISSION PRO HAC VICE
`
`
`
`I, David J. Galluzzo, declare as follows:
`
`1.
`
`I was admitted to the Connecticut Bar in 2006. I have been practicing law for over
`
`12 years. For more than 8 years my practice has focused primarily on patent litigation.
`
`2.
`
`3.
`
`Over the course of my career, I have been counsel in over 10 patent litigations.
`
`I am a member in good standing of the Bars of New York and Connecticut, and
`
`am admitted to practice before the U.S. District Courts for the Southern District of New York,
`
`Eastern District of New York, and the District of Delaware. My Connecticut Bar membership
`
`number is 426165 and my New York Bar membership number is 4495503.
`
`4.
`
`I have never been suspended or disbarred from practice before any court or
`
`administrative body.
`
`5.
`
`I have never had a court or administrative body deny my application for
`
`admission to practice.
`
`6.
`
`I have read and will comply with the Patent Office Trial Practice Guide and the
`
`Board’s Rules for Practice for Trials, as set forth in 37 C.F.R. Part 42.
`
`7.
`
`I agree to be subject to the United States Patent and Trademark Office Rules of
`
`Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under
`
`37 C.F.R. § 11.19(a).
`
`8.
`
`I have currently applied to appear pro hac vice in the following related proceeding
`
`before the United States Patent and Trademark Office IPR2017-00293. I have not applied to
`
`appear pro hac vice before the United States Patent and Trademark Office in any other
`
`proceedings in the last three years.
`
`9.
`
`I am intimately familiar with the subject matter of U.S. Patent No. 8,846,100. I
`
`am also intimately familiar with amphetamine salt formulations, such as Adderall XR® as a
`
`
`
`result of my preparation and research in this matter. I have represented a number of life sciences
`
`and pharmaceutical companies in patent litigation matters before Federal district courts. In
`
`addition, I am a former pharmaceutical scientist with close to ten years of chemistry experience.
`
`The technology in these disputes included pharmaceutical compounds and method-of-treatment
`
`claims.
`
`10.
`
`I hereby declare that all statements made herein of my own knowledge are true
`
`and that all statements made on information and belief are believed to be true; and further that
`
`these statements and the like are punishable by fine, imprisonment, or both under Section 1001
`
`of Title 18 of the United States Code.
`
`
`
`
`
`Date: January 24, 2019
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`By: /s/ David J. Galluzzo
` David J. Galluzzo
` Lucas & Mercanti, LLP
` 30 Broad Street
` New York, New York 10004
`
`